ENDOVASC, you have got to read this!!

December 16, 2003 Montgomery Texas

Endovasc Limited Inc. (ENVC.OB)
550 Club Drive, Suite 440 Montgomery, TX 77316
Phone: (936) 448-2222 / www.endovasc.com

December 16, 2003
This morning former CFO M. Dwight Cantrell, Board of director member
Diane Dottavio and a former member of the companies compensation
committee the Honorable Judge Ken Reilly accompanied by a local police
office escorted President and CEO Dr. David Summers from the offices
of Endovasc Limited Inc. in Montgomery Texas.

Friday on advice from corporate counsel, Endovasc called for the
immediate resignation of M. Dwight Cantrell and likewise the immediate
dismissal of CP Inc.
This follows an internal investigation of Cantrell and CP Inc.,
initiated by Dr. Summers last Monday into the activities of numerous
questionable share sale transactions of the company stock of Endovasc
by Cantrell as CFO, his qualifications and capability as CFO,
Cantrells relationship to CP Inc., and the legality of that entity and
it's contract with Endovasc.
Endovasc contracted with CP Inc. for Cantrells services as CFO.
Cantrell describes CP Inc., as a family trust and himself as an
employee. CP Inc., is reportedly owned and controlled by immediate
family members of Cantrell and by contracting with CP Inc. potential
conflicts of interest to Endovasc existed. Further Cantrell is not
qualified to hold a position of CFO, or capable of being
a director of Endovasc. Cantrell is not a CPA or even a qualified
accountant.
This investigation and initial findings were subsequently reported to
the SEC by Dr. Summers.
Share sale transactions initiated by Cantrell and CP Inc., are still
being reviewed.

Immediately during Dr. Summers brief absence it is reported that Diane
Dottavio has been appointed as President and CEO of Endovasc.

Endovasc, Inc. develops, markets and licenses biopharmaceutical
products, particularly liposomal drug delivery methods, for the human
healthcare industry. The Company develops liposomes, which are
microscopic cell-like spheres composed of a thin, durable lipid
membrane surrounding a hollow compartment. Liposomes entrap and
protect drugs from degradation in the blood stream and can be
engineered to regulate the transport of molecules across their outer
membrane. Using this technology, Endovasc is developing products that
deliver drugs to their intended target and release them with
efficiency and control. Its product development is focused on two core
products: Liprostin and Angiogenix.

@@@@@@@@@@@@@@REPOST FROM RAGINGBULL MESSAGE BOARDS
CHECK IT OUT FOR YOURSELF

http://www.ragingbull.lycos.com/mboa...cgi?board=EVSC

Mr. Tom Baudhuin
U.S. Securities Exchange Commission
Enforcement Division
Ft. Worth, Texas

Dear Mr. Baudhuin:

This letter is further to my today's telecom and substantiating a
earlier telephone voice mail
made to Barbara Ray of the Enforcement Division on or about December
8, 2003 when I called
to notify the Commission that I had expressed concerns as the Chief
Executive Officer of
Endovasc Inc., (OTC BB ENSV) over potential violations of the 1932
Act, and particularly the
Sorbannes/Oxly Act within my Company. I have been particularly
disturbed over an Agreement
between Endovasc, Inc. and The Baladore Group of Phoenix, Arizona
which was acting as a
Broker/Dealer in our securities to foreign nationals and/or exempt
U.S. citizens. Of particular
concern was the deal itself which carried a 50% discount to the
Company but according to my
Board of Directors was the "best we could do under the circumstances."
The major concern was
a continued drop in our stock price although I was assured that stock
sold under Regulation S
was restricted for one year, and the price drop was not the result of
shares coming back in to the
Country in circumvention of the Regulation. I instructed CFO and his
assistant to request a
random sampling of the subscribers to ascertain and validate some
degree of verification, no
action was taken was taken that I could physically verify. I
instructed my CFO and his
coordinator to terminate the deal during a telephone conversation I
made from Rome while
presenting at a medical conference on or about November 26, 2002. I
followed up with a
face-to-face meeting the next week in my office upon returning from
Europe. I was assured that
no more shares would be sold. One week later I was presented with a
sign-off form from
Baladore that represented that more shares had been sold and in order
to be reimbursed by
Baladore, I was put into a compromise with my instructions. I signed
for reimbursement for the
additional shares that represented about 200,000 shares, then
terminated the CFO's coordinator,
who was handling the logistics for the current CFO.

I called a meeting of the Board of Directors during the same week and
asked for the resignation
of the CFO. It had been disclosed that not only was the CFO paying
himself cash and shares
through his own private company which had been represented as a public
accounting firm in the
past, but was actually a family property trust administered by Mr.
Cantrell for and on behalf of
numerous family members. During the meeting, I teleconferenced the
opinion of our securities
counsel, Mr. Larry Wilson, Esq who confirmed to Mr. Cantrell that his
actions and inability to
perform as CFO had put the Company, its directors and Shareholders in
grave risk. Upon hearing
advise from Mr. Wilson, Mr. Cantrell told the Board,..."if my actions
have put the Board and the
Company into risk, then I WILL resign." He then asked for the weekend
to consider his options.
In order to accommodate this request the meeting was recessed until
Tuesday, December 16,
2003.

On Tuesday, Mr. Cantrell and Ms. Dottavio presented themselves to the
meeting. They were
accompanied by Judge Ken Reilly and one of his police officers,
(Officer Whitehead?). Mr.
Cantrell asked the chair if he could have the floor stating that he
not only would he not resign
but made a motion to remove me from the Chair and my position as CEO.
Obviously a takeover
plan was in effect and Ms. Dottavio had prepared herself to cooperate
with Mr. Cantrell's wish.

Judge Reilly then ordered me to hand over my keys, electronic pass
card, and to empty my brief
case in the presence of Ms. Dottavio and the Officer.
I asked to return to my office in order to get advice of counsel, Mr.
Wilson, who advised me to
cooperate with the Officer. Not wishing to disturb the peace with an
objection to this illegal act,
as well subject myself to further abuse and humiliation I complied and
both the Judge and the
Officer escorted me from the building.


To summarize, not only was this entire affair a blatant attempt to
distract me from my mission to
served the Shareholders best interest, but was a conspiracy of deceit
perpetrated with an act of
judicial oppression, upon the Shareholders by an incompetent CFO and
Director with direct
conflict of interest in holding both positions. My services to the
company are indispensable at
this moment in time, and my absence from the Board and Chief Executive
decision making puts
the Company and its shareholders at risk and irreparable harm. My sole
mission as founder,
CEO, Chairman and major stockholder in this company is to put in place
corporate governance
that is congruent with the Sorbannes/Oxly Act, SEC, the laws of the
State of Nevada and the
Charter and Bylaws of the Company in order to continue toward the goal
of returning maximum
investment to my shareholders share value. This mission is being
obstructed by two Directors
who have either obstructed these attempts or are incapable of
performing the duties required by
the above.

I have advised my Auditors and my SEC counsel of my investigation. I
have recited by
assessment of potential violations of the Act and requested an
exceptional audit on share sales.
Whether or not this will take place is now in the hands of the new
CEO, Ms Diane Dottavio and
the CFO, Mr. Dwight Cantrell.

Very sincerely yours.

ENDOVASC, INC.
Dr. David P. Summers,

@@@@@@@@@@@@@@REPOST FROM RAGINGBULL MESSAGE BOARDS
CHECK IT OUT FOR YOURSELF

http://www.ragingbull.lycos.com/mboa...cgi?board=EVSC

Mr. Tom Baudhuin
U.S. Securities Exchange Commission
Enforcement Division
Ft. Worth, Texas

Dear Mr. Baudhuin:

This letter is further to my today's telecom and substantiating a
earlier telephone voice mail
made to Barbara Ray of the Enforcement Division on or about December
8, 2003 when I called
to notify the Commission that I had expressed concerns as the Chief
Executive Officer of
Endovasc Inc., (OTC BB ENSV) over potential violations of the 1932
Act, and particularly the
Sorbannes/Oxly Act within my Company. I have been particularly
disturbed over an Agreement
between Endovasc, Inc. and The Baladore Group of Phoenix, Arizona
which was acting as a
Broker/Dealer in our securities to foreign nationals and/or exempt
U.S. citizens. Of particular
concern was the deal itself which carried a 50% discount to the
Company but according to my
Board of Directors was the "best we could do under the circumstances."
The major concern was
a continued drop in our stock price although I was assured that stock
sold under Regulation S
was restricted for one year, and the price drop was not the result of
shares coming back in to the
Country in circumvention of the Regulation. I instructed CFO and his
assistant to request a
random sampling of the subscribers to ascertain and validate some
degree of verification, no
action was taken was taken that I could physically verify. I
instructed my CFO and his
coordinator to terminate the deal during a telephone conversation I
made from Rome while
presenting at a medical conference on or about November 26, 2002. I
followed up with a
face-to-face meeting the next week in my office upon returning from
Europe. I was assured that
no more shares would be sold. One week later I was presented with a
sign-off form from
Baladore that represented that more shares had been sold and in order
to be reimbursed by
Baladore, I was put into a compromise with my instructions. I signed
for reimbursement for the
additional shares that represented about 200,000 shares, then
terminated the CFO's coordinator,
who was handling the logistics for the current CFO.

I called a meeting of the Board of Directors during the same week and
asked for the resignation
of the CFO. It had been disclosed that not only was the CFO paying
himself cash and shares
through his own private company which had been represented as a public
accounting firm in the
past, but was actually a family property trust administered by Mr.
Cantrell for and on behalf of
numerous family members. During the meeting, I teleconferenced the
opinion of our securities
counsel, Mr. Larry Wilson, Esq who confirmed to Mr. Cantrell that his
actions and inability to
perform as CFO had put the Company, its directors and Shareholders in
grave risk. Upon hearing
advise from Mr. Wilson, Mr. Cantrell told the Board,..."if my actions
have put the Board and the
Company into risk, then I WILL resign." He then asked for the weekend
to consider his options.
In order to accommodate this request the meeting was recessed until
Tuesday, December 16,
2003.

On Tuesday, Mr. Cantrell and Ms. Dottavio presented themselves to the
meeting. They were
accompanied by Judge Ken Reilly and one of his police officers,
(Officer Whitehead?). Mr.
Cantrell asked the chair if he could have the floor stating that he
not only would he not resign
but made a motion to remove me from the Chair and my position as CEO.
Obviously a takeover
plan was in effect and Ms. Dottavio had prepared herself to cooperate
with Mr. Cantrell's wish.

Judge Reilly then ordered me to hand over my keys, electronic pass
card, and to empty my brief
case in the presence of Ms. Dottavio and the Officer.
I asked to return to my office in order to get advice of counsel, Mr.
Wilson, who advised me to
cooperate with the Officer. Not wishing to disturb the peace with an
objection to this illegal act,
as well subject myself to further abuse and humiliation I complied and
both the Judge and the
Officer escorted me from the building.


To summarize, not only was this entire affair a blatant attempt to
distract me from my mission to
served the Shareholders best interest, but was a conspiracy of deceit
perpetrated with an act of
judicial oppression, upon the Shareholders by an incompetent CFO and
Director with direct
conflict of interest in holding both positions. My services to the
company are indispensable at
this moment in time, and my absence from the Board and Chief Executive
decision making puts
the Company and its shareholders at risk and irreparable harm. My sole
mission as founder,
CEO, Chairman and major stockholder in this company is to put in place
corporate governance
that is congruent with the Sorbannes/Oxly Act, SEC, the laws of the
State of Nevada and the
Charter and Bylaws of the Company in order to continue toward the goal
of returning maximum
investment to my shareholders share value. This mission is being
obstructed by two Directors
who have either obstructed these attempts or are incapable of
performing the duties required by
the above.

I have advised my Auditors and my SEC counsel of my investigation. I
have recited by
assessment of potential violations of the Act and requested an
exceptional audit on share sales.
Whether or not this will take place is now in the hands of the new
CEO, Ms Diane Dottavio and
the CFO, Mr. Dwight Cantrell.

Very sincerely yours.

ENDOVASC, INC.
Dr. David P. Summers,

@@@@@@@@@@@@@@REPOST FROM RAGINGBULL MESSAGE BOARDS
CHECK IT OUT FOR YOURSELF

http://www.ragingbull.lycos.com/mboa...cgi?board=EVSC

Mr. Tom Baudhuin
U.S. Securities Exchange Commission
Enforcement Division
Ft. Worth, Texas

Dear Mr. Baudhuin:

This letter is further to my today's telecom and substantiating a
earlier telephone voice mail
made to Barbara Ray of the Enforcement Division on or about December
8, 2003 when I called
to notify the Commission that I had expressed concerns as the Chief
Executive Officer of
Endovasc Inc., (OTC BB ENSV) over potential violations of the 1932
Act, and particularly the
Sorbannes/Oxly Act within my Company. I have been particularly
disturbed over an Agreement
between Endovasc, Inc. and The Baladore Group of Phoenix, Arizona
which was acting as a
Broker/Dealer in our securities to foreign nationals and/or exempt
U.S. citizens. Of particular
concern was the deal itself which carried a 50% discount to the
Company but according to my
Board of Directors was the "best we could do under the circumstances."
The major concern was
a continued drop in our stock price although I was assured that stock
sold under Regulation S
was restricted for one year, and the price drop was not the result of
shares coming back in to the
Country in circumvention of the Regulation. I instructed CFO and his
assistant to request a
random sampling of the subscribers to ascertain and validate some
degree of verification, no
action was taken was taken that I could physically verify. I
instructed my CFO and his
coordinator to terminate the deal during a telephone conversation I
made from Rome while
presenting at a medical conference on or about November 26, 2002. I
followed up with a
face-to-face meeting the next week in my office upon returning from
Europe. I was assured that
no more shares would be sold. One week later I was presented with a
sign-off form from
Baladore that represented that more shares had been sold and in order
to be reimbursed by
Baladore, I was put into a compromise with my instructions. I signed
for reimbursement for the
additional shares that represented about 200,000 shares, then
terminated the CFO's coordinator,
who was handling the logistics for the current CFO.

I called a meeting of the Board of Directors during the same week and
asked for the resignation
of the CFO. It had been disclosed that not only was the CFO paying
himself cash and shares
through his own private company which had been represented as a public
accounting firm in the
past, but was actually a family property trust administered by Mr.
Cantrell for and on behalf of
numerous family members. During the meeting, I teleconferenced the
opinion of our securities
counsel, Mr. Larry Wilson, Esq who confirmed to Mr. Cantrell that his
actions and inability to
perform as CFO had put the Company, its directors and Shareholders in
grave risk. Upon hearing
advise from Mr. Wilson, Mr. Cantrell told the Board,..."if my actions
have put the Board and the
Company into risk, then I WILL resign." He then asked for the weekend
to consider his options.
In order to accommodate this request the meeting was recessed until
Tuesday, December 16,
2003.

On Tuesday, Mr. Cantrell and Ms. Dottavio presented themselves to the
meeting. They were
accompanied by Judge Ken Reilly and one of his police officers,
(Officer Whitehead?). Mr.
Cantrell asked the chair if he could have the floor stating that he
not only would he not resign
but made a motion to remove me from the Chair and my position as CEO.
Obviously a takeover
plan was in effect and Ms. Dottavio had prepared herself to cooperate
with Mr. Cantrell's wish.

Judge Reilly then ordered me to hand over my keys, electronic pass
card, and to empty my brief
case in the presence of Ms. Dottavio and the Officer.
I asked to return to my office in order to get advice of counsel, Mr.
Wilson, who advised me to
cooperate with the Officer. Not wishing to disturb the peace with an
objection to this illegal act,
as well subject myself to further abuse and humiliation I complied and
both the Judge and the
Officer escorted me from the building.


To summarize, not only was this entire affair a blatant attempt to
distract me from my mission to
served the Shareholders best interest, but was a conspiracy of deceit
perpetrated with an act of
judicial oppression, upon the Shareholders by an incompetent CFO and
Director with direct
conflict of interest in holding both positions. My services to the
company are indispensable at
this moment in time, and my absence from the Board and Chief Executive
decision making puts
the Company and its shareholders at risk and irreparable harm. My sole
mission as founder,
CEO, Chairman and major stockholder in this company is to put in place
corporate governance
that is congruent with the Sorbannes/Oxly Act, SEC, the laws of the
State of Nevada and the
Charter and Bylaws of the Company in order to continue toward the goal
of returning maximum
investment to my shareholders share value. This mission is being
obstructed by two Directors
who have either obstructed these attempts or are incapable of
performing the duties required by
the above.

I have advised my Auditors and my SEC counsel of my investigation. I
have recited by
assessment of potential violations of the Act and requested an
exceptional audit on share sales.
Whether or not this will take place is now in the hands of the new
CEO, Ms Diane Dottavio and
the CFO, Mr. Dwight Cantrell.

Very sincerely yours.

ENDOVASC, INC.
Dr. David P. Summers,